Novartis Radioligand Therapy Launch in Belgium
Bringing innovative prostate cancer therapy to Belgium first and designing the national model that could scale.
€1.5M EIT Health / Horizon 2020 Grant
A multi-stakeholder coalition that outlived the grant — 1 of a handful selected from 276 applicants.
HPV Primary Screening, Belgium
Belgium's national shift from cytology to HPV primary screening, reimbursement secured.
NIPT Reimbursement, Belgium
World's first universal NIPT reimbursement and a reference model across Europe.